One in 5 of the highest-revenue drugs of 2022 was exclusively approved for rare conditions, accounting for more than 7% of US pharmaceutical spending.
Helen Mooney, MPH
Advertisement
Articles by Helen Mooney, MPH
Advertisement
Latest Updated Articles
US Spending on High-Revenue Rare Disease Drugs in 2022November 14th 2025
Advertisement
Advertisement
Trending on AJMC
1
Preparing Practices for the Next Era of Hepatitis B Care
2
Pharmacists Bridge the Vaccine Trust Gap as COVID-19 Persists
3
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
4
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
5